Cleveland Browns owners recently made a large donation for cancer research. Dee Haslam lives daily with a rare blood cancer ...
The owners of the Cleveland Browns football team, Dee and Jimmy Haslam, are planning to donate $12.5 million in an effort to ...
Single agent duvelisib demonstrated clinically meaningful response rates, including a substantial proportion of complete responses, in a heavily pretreated PTCL population ...
Regeneron and Telix announced a strategic radiopharma collaboration worth up to $4.3 billion. Daiichi Sankyo entered a $1.55 billion agreement with Suntory Holdings to transfer all shares in its ...
Delivering bispecifics and CAR T in community settings could improve access and lower costs but requires robust symptom ...
RedHill Talicia ® business transformed: Formation of Talicia Holdings Inc. (THI) and the U.S. co-commercialization partnership with Cumberland Pharmaceuticals ("Cumberland") (Nasdaq: CPIX), including ...
Military service members face disproportionate health risks, particularly for mental health, with exposure to environmental ...
Haslam shares a personal health battle, a common vaccine shows unexpected promise, and simple habit changes could transform ...
A post hoc analysis evaluates zanubrutinib vs acalabrutinib-venetoclax in treatment naive chronic lymphocytic leukemia using indirect comparisons of data from two phase 3 trials.
Hosted on MSN
New hope for chronic illness care decisions
From rheumatoid arthritis to chronic lymphocytic leukemia, new research is shifting how doctors and patients choose treatments — with timing, duration, and personalization at the center. Studies show ...
Eli Lilly has chalked up another victory in the chronic lymphocytic leukemia (CLL) space, as its BTK inhibitor Jaypirca delivered its fourth positive phase 3 readout in the blood cancer. Monday, Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results